Interview on Urgent Requirement SHUKRA LABORATORIES for Multiple positions.
About Shukra laboratories:-
Shukra Pharmaceuticals Limited has been established publicly on March 04, 1993. She is classified as a non-governmental company and is registered with the Registrar of Companies, Ahmedabad. Its authorized share capital is Rs. 120,000,000 and its paid up capital is Rs. 15,656,750 It is involved in the creation of other chemical products.
The annual general meeting (AGM) of Shukra Pharmaceuticals Limited (AGM) took place on September 12, 2017 and the balance sheet was filed on March 31, 2017, as per the records of the Ministry of Corporate Affairs (MCA).
Directors of Shukla Pharmaceuticals Ltd are Pall Sujay Mehta, Sujay Jyotindra Mehta, Tashesh Ramesh Chandra Shah, Sonal Chandrashekhar Patel, Chandreshbhai Dasharathalal Patel.
About overall pharmaceutical industry:-
India's pharmaceutical industry is at the third position in the world and is at 14th position. According to the Pharmaceuticals Department of the Ministry of Chemical and Fertilizers, the total income of Indian pharmaceutical companies was 21.04 billion US dollars between 2008 and September 2009. Hyderabad, Mumbai, Bangalore and Ahmedabad are the major pharmaceutical companies in India. In 2013 domestic market value was $ 13.8 billion.
The government started promoting the growth of drug production in the early 1960s and the Indian Patent Act 1970.However, the former Prime Minister P. V. In the 90's, financial liberalization was done. Dr. Narasimha Rao and the then Finance Minister Dr. Manmohan Singh has made the industry what he has made today. This patent work patented the design of food and medicines, and even if the patent process continues, it has been reduced for five to seven years.
In the absence of patent protection, the Indian market has unwanted multinational companies dominated by the market. After the exit of multinationals, Indian companies have developed their skills in Indian and global markets in the new process of reverse-engineering to create medicines at a lower cost. Even though some big companies have taken steps for drug renewal, the whole industry is still following the model of this business.
In the last financial year 2009-10, India's bio-pharmaceutical industry grew by 17 percent with a revenue of $ 1,737 billion ($ 3 billion). Bio-Pharma was the biggest contributor, which increased from 60% of the industry to 8,829 crores. Thereafter, Bio-services worth Rs.2,293 crores and Bio-agricultural production of Rs.19,936 crores were produced.
